Unison
Accessible omics data for faster drug discovery.
Unison accelerates drug discovery by making novel omics data accessible and affordable, in a privacy-first way.
Access to data is the biggest problem in drug discovery. Acquiring data is a difficult legal and technical process.
Unison’s federated architecture keeps the raw data secure for the data custodian while allowing researchers to train their ML models and run their analyses over it. Unison encodes, enriches, and integrates data in a central platform for easy access.
Founder
Daniel Sozonov
CEO
Daniel graduated from University College London with a degree in Management for Business. He previously founded a facial recognition company that reached over 100,000 daily users across 150 locations and received multiple awards.
Milestones
2022
Founded at Entrepreneur First